Rafael Holdings, Inc. Stock price

Equities

RFL

US75062E1064

Real Estate Development & Operations

Delayed Nyse 12:41:33 2024-03-28 pm EDT 5-day change 1st Jan Change
1.71 USD -0.58% Intraday chart for Rafael Holdings, Inc. 0.00% -6.56%
Sales 2022 410K Sales 2023 279K Capitalization 48.59M
Net income 2022 -125M Net income 2023 -1M EV / Sales 2022 90.2 x
Net cash position 2022 11.54M Net cash position 2023 21.5M EV / Sales 2023 97.1 x
P/E ratio 2022
-0.32 x
P/E ratio 2023
-24.8 x
Employees 13
Yield 2022 *
-
Yield 2023
-
Free-Float 77.73%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.58%
Current month-0.58%
1 month-1.16%
3 months-5.00%
6 months-12.31%
Current year-6.56%
More quotes
1 week
1.67
Extreme 1.6701
1.76
1 month
1.63
Extreme 1.63
1.79
Current year
1.62
Extreme 1.62
1.95
1 year
1.44
Extreme 1.44
2.52
3 years
1.44
Extreme 1.44
66.44
5 years
1.44
Extreme 1.44
66.44
10 years
1.44
Extreme 1.44
66.44
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 21-03-14
Director of Finance/CFO 53 17-11-30
Chairman 68 17-08-16
Members of the board TitleAgeSince
Chairman 68 17-08-16
Director/Board Member 80 18-03-25
Director/Board Member 73 18-02-28
More insiders
Date Price Change Volume
24-03-28 1.71 -0.58% 9 410
24-03-27 1.72 +0.58% 8,187
24-03-26 1.71 +1.18% 23,519
24-03-25 1.69 -1.17% 35,688
24-03-22 1.71 0.00% 13,754

Delayed Quote Nyse, March 28, 2024 at 12:41 pm EDT

More quotes
Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. The Company's segments include healthcare and real estate. The Company's investments include Cornerstone Pharmaceuticals, Inc., which is a cancer metabolism-based therapeutics company; LipoMedix Pharmaceuticals Ltd., which is a clinical-stage pharmaceutical company; Barer Institute Inc., which is a preclinical cancer metabolism research operation; Cyclo Therapeutics Inc., which is a clinical-stage biotechnology company dedicated to developing medicines for patients and families living with diseases through its therapeutic asset like Trappsol and Cyclo; Day Three Labs, Inc., which offers pharmaceutical-grade technology like Unlokt, and Rafael Medical Devices, LLC, which is an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. Its real estate segment comprises of a portion of a commercial building in Israel.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
  1. Stock
  2. Equities
  3. Stock Rafael Holdings, Inc. - Nyse